GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice

B-cell lymphoma 6 (BCL6) is a zinc finger transcriptional repressor possessing a BTB–POZ (BR-C, ttk, and bab for BTB; pox virus and zinc finger for POZ) domain, which is required for homodimerization and association with corepressors. BCL6 has multiple roles in normal immunity, autoimmunity, and som...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearce, Andrew C., Bamford, Mark J., Barber, Ruth, Bridges, Angela, Convery, Maire A., Demetriou, Constantinos, Evans, Sian, Gobbetti, Thomas, Hirst, David J., Holmes, Duncan S., Hutchinson, Jonathan P., Jayne, Sandrine, Lezina, Larissa, McCabe, Michael T., Messenger, Cassie, Morley, Joanne, Musso, Melissa C., Scott-Stevens, Paul, Manso, Ana Sousa, Schofield, Jennifer, Slocombe, Tom, Somers, Don, Walker, Ann L., Wyce, Anastasia, Zhang, Xi-Ping, Wagner, Simon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350397/
https://www.ncbi.nlm.nih.gov/pubmed/34274316
http://dx.doi.org/10.1016/j.jbc.2021.100928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350397/
https://www.ncbi.nlm.nih.gov/pubmed/34274316
http://dx.doi.org/10.1016/j.jbc.2021.100928

Ejemplares similares